<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-714X</journal-id>
<journal-title><![CDATA[Revista de la OFIL ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. OFIL·ILAPHAR]]></abbrev-journal-title>
<issn>1699-714X</issn>
<publisher>
<publisher-name><![CDATA[Organización de Farmacéuticos Ibero-Latinoamericanos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-714X2025000400010</article-id>
<article-id pub-id-type="doi">10.4321/s1699-714x2025000400009</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Facing the Burden of Cardiovascular Diseases in Latin America: A Case Report of an In-Service Specialist Training to Clinical Pharmacists in Brazil]]></article-title>
<article-title xml:lang="es"><![CDATA[Enfrentando Enfermedades Cardiovasculares en Latinoamerica: Reporte de Caso de Capacitación en Servicio para Farmacéuticos Clínicos Especialistas en Brasil]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[EINSFELD]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[FLORIANO DOS SANTOS]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[FAGUNDES]]></surname>
<given-names><![CDATA[M.L.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Clinical Pharmacy Division, Hospital de Clínicas de Porto Alegre  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Jephesson Alex Floriano dos Santos, Clinical Pharmacy Division, Surgical Intensive Care Unit, Federal University of Paraná Hospital de Clínicas  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Marlise Lara Fagundes, Canoas Healthcare Foundation (Fundação Municipal de Saúde de Canoas)  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2025</year>
</pub-date>
<volume>35</volume>
<numero>4</numero>
<fpage>356</fpage>
<lpage>359</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-714X2025000400010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-714X2025000400010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-714X2025000400010&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: Cardiovascular diseases are the leading causes of mortality in Brazil, and cardiology specialized pharmacists can contribute to improve patients outcomes, in a variety of settings. This study aims to describe a seminal in-service training program in Cardiology, targeting newly hired pharmacists with no prior experience in the area. Methods: Two generalist pharmacists received a 60-day training consisting of 3 phases (theoretical classes, pharmacist &#8216;shadowing&#8217; and supervised practice) with a formercardiology pharmacist. Evaluation of the program was carried out: December 20 to May 21 pharmacists&#8217; interventions were retrospectively analyzed and categorized. Results: Following the training program, each trainee attended a mean of 75.7 ± 13.3 hospitalizations per month, with half of the patients receiving at least 1 intervention in their pharmacotherapy, suggested by the pharmacist. Conclusion: The proposed in-service program may represent a feasible option to general pharmacist&#8217;s and institutions in need for specialized training in cardiology]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: Las enfermedades cardiovasculares son las principales causas de mortalidad en Brasil, y los farmacéuticos especialistas en cardiología pueden contribuir a mejorar los resultados de los pacientes, en una variedad de escenarios. Este estudio tiene como objetivo describir un programa seminal de capacitación en servicio, en el área de Cardiología, dirigido a farmacéuticos recién contratados sin experiencia previa. Métodos: Dos farmacéuticos generalistas recibieron una formación de 60 días que constaba de 3 fases (clases teóricas, seguimiento del farmacéutico y práctica supervisada) con un farmacéutico especialista en cardiología. Se realizó la evaluación del programa: de diciem bre 2020 a mayo 2021 se analizaron y categorizaron retrospectivamente las intervenciones de los farmacéuticos. Resultados: Siguiendo el programa de formación, cada practicante atendió una media de 75,7 ± 13,3 hospitalizaciones al mes, recibiendo la mitad de los pacientes al menos una intervención en su farmacoterapia, sugerida por el farmacéutico. Conclusión: El programa en servicio propuesto puede representar una opción factible para los farmacéuticos generales y las instituciones que necesitan farmacéuticos con capacitación especializada en cardiología.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[cardiovascular]]></kwd>
<kwd lng="en"><![CDATA[pharmacist]]></kwd>
<kwd lng="en"><![CDATA[pharmacy education]]></kwd>
<kwd lng="en"><![CDATA[pharmaceutical care]]></kwd>
<kwd lng="en"><![CDATA[team-based care]]></kwd>
<kwd lng="en"><![CDATA[training]]></kwd>
<kwd lng="es"><![CDATA[cardiovascular]]></kwd>
<kwd lng="es"><![CDATA[farmacéutico]]></kwd>
<kwd lng="es"><![CDATA[educación farmacéutica]]></kwd>
<kwd lng="es"><![CDATA[atención farmacéutica]]></kwd>
<kwd lng="es"><![CDATA[atención en equipo]]></kwd>
<kwd lng="es"><![CDATA[formación.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="">
<collab>International Pharmaceutical Federation (FIP)</collab>
<source><![CDATA[The FIP Development Goals Report 2021: Setting goals for the decade ahead [Internet]. The Hague: International Pharmaceutical Federation]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Einsfeld]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hastenteufel]]></surname>
<given-names><![CDATA[LCT]]></given-names>
</name>
<name>
<surname><![CDATA[Taber]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Clausell]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Goldraich]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Challenges for expansion of thoracic transplant clinical pharmacy in a developing country: comparison with U.S. accredited centres and call for action]]></article-title>
<source><![CDATA[Journal of Clinical Pharmacy and Therapeutics]]></source>
<year>2021</year>
<volume>7</volume>
<page-range>588-91</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="">
<collab>harmaceutical Care Network Europe Association [Internet]</collab>
<source><![CDATA[The PCNE Classification V 9.1]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="">
<collab>Federal Pharmacy Council [Internet]</collab>
<source><![CDATA[Residency Hub]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Duncan]]></surname>
<given-names><![CDATA[BB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular Health in Brazil: Trends and Perspectives]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2016</year>
<volume>133</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>422-33</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roth]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Mensah]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[CO]]></given-names>
</name>
<name>
<surname><![CDATA[Addolorato]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ammirati]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Baddour]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group (2020). Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study]]></article-title>
<source><![CDATA[Journal of the American College of Cardiology]]></source>
<year>2020</year>
<volume>76</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>2982-3021</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[GMM]]></given-names>
</name>
<name>
<surname><![CDATA[Brant]]></surname>
<given-names><![CDATA[LCC]]></given-names>
</name>
<name>
<surname><![CDATA[Polanczyk]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Biolo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nascimento]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Malta]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estatística Cardiovascular &#8211; Brasil 2020]]></article-title>
<source><![CDATA[Arq. Bras. Cardiol]]></source>
<year>2020</year>
<volume>115</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>308-439</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brant]]></surname>
<given-names><![CDATA[LCC]]></given-names>
</name>
<name>
<surname><![CDATA[Nascimento]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Passos]]></surname>
<given-names><![CDATA[VMA]]></given-names>
</name>
<name>
<surname><![CDATA[Duncan]]></surname>
<given-names><![CDATA[BB]]></given-names>
</name>
<name>
<surname><![CDATA[Bensenõr]]></surname>
<given-names><![CDATA[IJM]]></given-names>
</name>
<name>
<surname><![CDATA[Malta]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Variations and particularities in cardiovascular disease mortality in Brazil and Brazilian states in 1990 and 2015: estimates from the Global Burden of Disease. Variações e diferenciais da mortalidade por doença cardiovascular no Brasil e em seus estados, em 1990 e 2015: estimativas do Estudo Carga Global de Doença]]></article-title>
<source><![CDATA[Brazilian journal of epidemiology]]></source>
<year>2017</year>
<volume>20</volume>
<numero>^sSuppl01</numero>
<issue>^sSuppl01</issue>
<supplement>Suppl01</supplement>
<page-range>116-28</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chisholm-Burns]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Kim Lee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Spivey]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Slack]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Herrier]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Hall-Lipsy]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[US pharmacists&#8217; effect as team members on patient care: systematic review and meta-analyses]]></article-title>
<source><![CDATA[Medical care]]></source>
<year>2010</year>
<volume>48</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>923-33</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abolbashari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Macaulay]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
<name>
<surname><![CDATA[Whayne]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
<name>
<surname><![CDATA[Mukherjee]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Saha]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polypharmacy in Cardiovascular Medicine: Problems and Promises!.]]></article-title>
<source><![CDATA[Cardiovascular &amp; hematological agents in medicinal chemistry]]></source>
<year>2017</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Lambert]]></surname>
<given-names><![CDATA[-Kerzner A]]></given-names>
</name>
<name>
<surname><![CDATA[Carey]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Fahdi]]></surname>
<given-names><![CDATA[IE]]></given-names>
</name>
<name>
<surname><![CDATA[Bryson]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Melnyk]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial]]></article-title>
<source><![CDATA[JAMA internal medicine]]></source>
<year>2014</year>
<volume>174</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>186-93</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Rogers]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Daly]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The potency of team-based care interventions for hypertension: a meta-analysis]]></article-title>
<source><![CDATA[Archives of internal medicine]]></source>
<year>2009</year>
<volume>169</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>1748-55</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santschi]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials]]></article-title>
<source><![CDATA[Diabetes care]]></source>
<year>2012</year>
<volume>35</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>2706-17</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koshman]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Charrois]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Simpson]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[McAlister]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Tsuyuki]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacist care of patients with heart failure: a systematic review of randomized trials]]></article-title>
<source><![CDATA[Archives of internal medicine]]></source>
<year>2008</year>
<volume>168</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>687-94</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunn]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Birtcher]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Beavers]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Baker]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
<name>
<surname><![CDATA[Brouse]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Page]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of the clinical pharmacist in the care of patients with cardiovascular disease]]></article-title>
<source><![CDATA[Journal of the American College of Cardiology]]></source>
<year>2015</year>
<volume>66</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>2129-39</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
